PubMed

Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT).

Bingley PJ, Mahon JL, Gale EA; European Nicotinamide Diabetes Intervention Trial Group.

Diabetes Care. 2008 Jan;31(1):146-50. Epub 2007 Oct 24.PMID: 17959864 [PubMed - indexed for MEDLINE]Related articlesFree article

Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk.

Bingley PJ, Gale EA; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group.

Diabetologia. 2006 May;49(5):881-90. Epub 2006 Mar 3.PMID: 16514546 [PubMed - indexed for MEDLINE]Related articles

Insulin resistance is a risk factor for progression to type 1 diabetes.

Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC.

Diabetologia. 2004 Oct;47(10):1661-7. Epub 2004 Oct 6. Erratum in: Diabetologia. 2004 Dec;47(12):2247. PMID: 15480539 [PubMed - indexed for MEDLINE]Related articles

Role of insulin resistance in predicting progression to type 1 diabetes.

Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP; Diabetes Prevention Trial-Type 1 Study Group.

Diabetes Care. 2007 Sep;30(9):2314-20. Epub 2007 May 29.PMID: 17536068 [PubMed - indexed for MEDLINE]Related articlesFree article

Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives.

Achenbach P, Bonifacio E, Williams AJ, Ziegler AG, Gale EA, Bingley PJ; ENDIT Group.

Diabetologia. 2008 Mar;51(3):488-92. Epub 2008 Jan 9.PMID: 18193190 [PubMed - indexed for MEDLINE]Related articles

Intervening before the onset of Type 1 diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT).

European Nicotinamide Diabetes Intervention Trial Group.

Diabetologia. 2003 Mar;46(3):339-46. Epub 2003 Feb 27. Erratum in: Diabetologia. 2003 Sep;46(9):1296. PMID: 12687331 [PubMed - indexed for MEDLINE]Related articles

Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?

Schatz D, Cuthbertson D, Atkinson M, Salzler MC, Winter W, Muir A, Silverstein J, Cook R, Maclaren N, She JX, Greenbaum C, Krischer J.

Pediatr Diabetes. 2004 Jun;5(2):72-9.PMID: 15189492 [PubMed - indexed for MEDLINE]Related articles

Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.

Füchtenbusch M, Rabl W, Grassl B, Bachmann W, Standl E, Ziegler AG.

Diabetologia. 1998 May;41(5):536-41.PMID: 9628270 [PubMed - indexed for MEDLINE]Related articles

Progression to diabetes in relatives with islet autoantibodies. Is it inevitable?

Gardner SG, Gale EA, Williams AJ, Gillespie KM, Lawrence KE, Bottazzo GF, Bingley PJ.

Diabetes Care. 1999 Dec;22(12):2049-54.PMID: 10587841 [PubMed - indexed for MEDLINE]Related articlesFree article

The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1 diabetes. DENIS Group.

Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G, Kolb H.

Diabetes. 1998 Jun;47(6):980-4.PMID: 9604880 [PubMed - indexed for MEDLINE]Related articlesFree article

European Nicotinamide Diabetes Intervention Trial (ENDIT): a randomised controlled trial of intervention before the onset of type 1 diabetes.

Gale EA, Bingley PJ, Emmett CL, Collier T; European Nicotinamide Diabetes Intervention Trial (ENDIT) Group.

Lancet. 2004 Mar 20;363(9413):925-31.PMID: 15043959 [PubMed - indexed for MEDLINE]Related articles

Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+ relatives: the ICARUS data set. Islet Cell Antibody Register Users Study.

Bingley PJ.

Diabetes. 1996 Dec;45(12):1720-8.PMID: 8922357 [PubMed - indexed for MEDLINE]Related articles

Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients.

Vardi P, Crisa L, Jackson RA.

Diabetologia. 1991 Feb;34(2):93-102.PMID: 2065854 [PubMed - indexed for MEDLINE]Related articles

Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.

Lorini R, Alibrandi A, Vitali L, Klersy C, Martinetti M, Betterle C, d'Annunzio G, Bonifacio E; Pediatric Italian Study Group of Prediabetes.

Diabetes Care. 2001 Jul;24(7):1210-6.PMID: 11423504 [PubMed - indexed for MEDLINE]Related articlesFree article

Insulin resistance and progression to type 1 diabetes in the European Nicotinamide Diabetes Intervention Trial (ENDIT): response to Bingley et al.

Wilkin TJ.

Diabetes Care. 2008 Apr;31(4):e29. No abstract available. PMID: 18375430 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of insulin administration in a group of high-risk, non-diabetic, first-degree relatives of Type 1 diabetic patients: an open pilot trial.

Rodríguez-Villar C, Conget I, Casamitjana R, Ercilla G, Gomis R.

Diabet Med. 1999 Feb;16(2):160-3.PMID: 10229311 [PubMed - indexed for MEDLINE]Related articles

Islet autoantibodies, nationality and gender: a multinational screening study in first-degree relatives of patients with Type I diabetes.

Williams AJ, Bingley PJ, Moore WP, Gale EA; ENDIT Screening Group. European Nicotinamide Diabetes Intervention Trial.

Diabetologia. 2002 Feb;45(2):217-23.PMID: 11935153 [PubMed - indexed for MEDLINE]Related articles

Optimized autoantibody-based risk assessment in family members. Implications for future intervention trials.

Bingley PJ, Williams AJ, Gale EA.

Diabetes Care. 1999 Nov;22(11):1796-801.PMID: 10546010 [PubMed - indexed for MEDLINE]Related articlesFree article

Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.

Pietropaolo M, Yu S, Libman IM, Pietropaolo SL, Riley K, LaPorte RE, Drash AL, Mazumdar S, Trucco M, Becker DJ.

Pediatr Diabetes. 2005 Dec;6(4):184-92.PMID: 16390386 [PubMed - indexed for MEDLINE]Related articles

Combination of autoantibody markers and risk for development of type 1 diabetes: results from a large french cohort of family members.

Thivolet C, Nicolino M, Monbeig S, Estour B, Halimi S, Robert M, Orgiazzi J, Chatelain P; GRADI study.

Diabetes Metab. 2002 Sep;28(4 Pt 1):279-85.PMID: 12442065 [PubMed - indexed for MEDLINE]Related articlesFree article